Brief: Fosun Pharma Says Henlius Biotech's Pertuzumab Injection Approved By China Regulator
29/05/2026 11:03
BRIEF-Fosun Pharma Says Henlius Biotech's Pertuzumab Injection Approved By China Regulator May 29 (Reuters) - Fosun Pharma 600196.SS:
SAYS UNIT HENLIUS BIOTECH'S PERTUZUMAB INJECTION APPLICATION APPROVED BY CHINA REGULATOR
Further company coverage: 600196.SS
(Reporting by Beijing Newsroom)
((Ethan.Wang@thomsonreuters.com;))
Recent news on Shanghai Fosun Pharmaceutical
See all newsSHH Margin Trading -- Fosun Pharma Margin Long Amount is 1,592 (x10000) yuan, Short Selling Volume is 5 (x10000) shares
SHH Margin Trading -- Fosun Pharma Margin Long Amount is 2,031 (x10000) yuan, Short Selling Volume is 1 (x10000) shares
SHH Margin Trading -- Fosun Pharma Margin Long Amount is 2,109 (x10000) yuan, Short Selling Volume is 10 (x10000) shares
SHH Margin Trading -- Fosun Pharma Margin Long Amount is 2,131 (x10000) yuan, Short Selling Volume is 0.21 (x10000) shares
SHH Margin Trading -- Fosun Pharma Margin Long Amount is 1,865 (x10000) yuan, Short Selling Volume is 0.15 (x10000) shares